vTv Therapeutics Inc.VTVTNASDAQ
Loading
Year-over-year SG&A expense growth
| Period | Value |
|---|---|
| Q4 2025 | 8.10% |
| Q3 2025 | 1.69% |
| Q2 2025 | -1.50% |
| Q1 2025 | 37.31% |
| Q4 2024 | -18.49% |
| Q3 2024 | -11.68% |
| Q2 2024 | -6.59% |
| Q1 2024 | 54.85% |
| Q4 2023 | 0.98% |
| Q3 2023 | -23.12% |
| Q2 2023 | -5.05% |
| Q1 2023 | 45.94% |
| Q4 2022 | -9.34% |
| Q3 2022 | 43.86% |
| Q2 2022 | -65.76% |
| Q1 2022 | 11.05% |
| Q4 2021 | 116.84% |
| Q3 2021 | -0.94% |
| Q2 2021 | 3.60% |
| Q1 2021 | 6.34% |
| Q4 2020 | 90.01% |
| Q3 2020 | -36.81% |
| Q2 2020 | -30.82% |
| Q1 2020 | 23.18% |
| Q4 2019 | 12.37% |
| Q3 2019 | -26.00% |
| Q2 2019 | 0.25% |
| Q1 2019 | 15.10% |
| Q4 2018 | -3.94% |
| Q3 2018 | -21.15% |
| Q2 2018 | 21.37% |
| Q1 2018 | -23.22% |
| Q4 2017 | 14.41% |
| Q3 2017 | -14.58% |
| Q2 2017 | 6.41% |
| Q1 2017 | 25.40% |
| Q4 2016 | -6.21% |
| Q3 2016 | -10.14% |
| Q2 2016 | 3.53% |
| Q1 2016 | 8.90% |